Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Academic Article

Publication Date:

2017

abstract:

https://www.ncbi.nlm.nih.gov/pubmed/28611125

Iris type:

1.1 Articolo in rivista

Keywords:

Administration, Oral

List of contributors:

Maurer, M. S.; Elliott, P.; Merlini, G.; Shah, S. J.; Cruz, M. W.; Flynn, A.; Gundapaneni, B.; Hahn, C.; Riley, S.; Schwartz, J.; Sultan, M. B.; Rapezzi, C.; Investigators, Attr-Act Study

Authors of the University:

MERLINI GIAMPAOLO

Handle:

https://iris.unipv.it/handle/11571/1371068

Published in:

CIRCULATION. HEART FAILURE

Journal